192 related articles for article (PubMed ID: 18198210)
21. Peptides selected from a phage display library with an HIV-neutralizing antibody elicit antibodies to HIV gp120 in rabbits, but not to the same epitope.
Wilkinson RA; Evans JR; Jacobs JM; Slunaker D; Pincus SH; Pinter A; Parkos CA; Burritt JB; Teintze M
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1416-27. PubMed ID: 18184085
[TBL] [Abstract][Full Text] [Related]
22. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.
Doores KJ; Fulton Z; Huber M; Wilson IA; Burton DR
J Virol; 2010 Oct; 84(20):10690-9. PubMed ID: 20702629
[TBL] [Abstract][Full Text] [Related]
23. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.
Dunlop DC; Bonomelli C; Mansab F; Vasiljevic S; Doores KJ; Wormald MR; Palma AS; Feizi T; Harvey DJ; Dwek RA; Crispin M; Scanlan CN
Glycobiology; 2010 Jul; 20(7):812-23. PubMed ID: 20181792
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy.
Martines E; García I; Marradi M; Padro D; Penadés S
Langmuir; 2012 Dec; 28(51):17726-32. PubMed ID: 23198686
[TBL] [Abstract][Full Text] [Related]
25. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
[TBL] [Abstract][Full Text] [Related]
26. An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.
Joyce JG; Krauss IJ; Song HC; Opalka DW; Grimm KM; Nahas DD; Esser MT; Hrin R; Feng M; Dudkin VY; Chastain M; Shiver JW; Danishefsky SJ
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15684-9. PubMed ID: 18838688
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose.
Stanfield RL; De Castro C; Marzaioli AM; Wilson IA; Pantophlet R
Glycobiology; 2015 Apr; 25(4):412-9. PubMed ID: 25380763
[TBL] [Abstract][Full Text] [Related]
28. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
30. Interrogation of side chain biases for oligomannose recognition by antibody 2G12 via structure-guided phage display libraries.
Lin TY; Lai JR
Bioorg Med Chem; 2017 Oct; 25(20):5790-5798. PubMed ID: 28947103
[TBL] [Abstract][Full Text] [Related]
31. A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity.
Doores KJ; Fulton Z; Hong V; Patel MK; Scanlan CN; Wormald MR; Finn MG; Burton DR; Wilson IA; Davis BG
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17107-12. PubMed ID: 20852065
[TBL] [Abstract][Full Text] [Related]
32. Reintroduction of the 2G12 epitope in an HIV-1 clade C gp120.
Chen H; Xu X; Bishop A; Jones IM
AIDS; 2005 May; 19(8):833-5. PubMed ID: 15867500
[TBL] [Abstract][Full Text] [Related]
33. A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design.
Clark BE; Auyeung K; Fregolino E; Parrilli M; Lanzetta R; De Castro C; Pantophlet R
Chem Biol; 2012 Feb; 19(2):254-63. PubMed ID: 22365608
[TBL] [Abstract][Full Text] [Related]
34. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
Murali R; Kieber-Emmons T
J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
[TBL] [Abstract][Full Text] [Related]
35. A structure-based approach to a synthetic vaccine for HIV-1.
Cabezas E; Wang M; Parren PW; Stanfield RL; Satterthwait AC
Biochemistry; 2000 Nov; 39(47):14377-91. PubMed ID: 11087390
[TBL] [Abstract][Full Text] [Related]
36. Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry.
Platt EJ; Gomes MM; Kabat D
Proc Natl Acad Sci U S A; 2012 May; 109(20):7829-34. PubMed ID: 22547820
[TBL] [Abstract][Full Text] [Related]
37. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
[TBL] [Abstract][Full Text] [Related]
38. Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen.
Liu CC; Zhai C; Zheng XJ; Ye XS
ACS Chem Biol; 2016 Jun; 11(6):1702-9. PubMed ID: 27088577
[TBL] [Abstract][Full Text] [Related]
39. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
40. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
Pantophlet R; Wilson IA; Burton DR
Protein Eng Des Sel; 2004 Oct; 17(10):749-58. PubMed ID: 15542540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
